Mutant p53 Fitness Modeling for Immunotherapy Selection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods fail to accurately predict the fitness of mutant p53 proteins, which are crucial for determining the effectiveness of immunotherapies such as immune checkpoint inhibitor therapy and adoptive T-cell therapy in patients with TP53 mutations, as they do not account for the complex interplay between pro-oncogenic advantage and immunogenic cost.
Innovation Solution
A multi-parameter orthogonal model is applied to generate fitness scores for p53 missense mutations by assessing pro-oncogenic advantage and immunogenic cost, using metrics like transactivation levels of target genes and binding affinities to MHC class I molecules, and optimizing these with divergence-based statistical analysis to identify suitable therapies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If existing methods are used to predict mutant p53 fitness, then the prediction process is simple, but the prediction accuracy is insufficient because they do not account for the complex interplay between pro-oncogenic advantage and immunogenic cost
Solution Approach 1:
The fitness prediction is segmented into two independent components: pro-oncogenic advantage metric (based on transactivation levels of target genes) and immunogenic cost metric (based on binding affinities to MHC class I molecules). These segmented metrics are calculated separately and then integrated through a multi-parameter orthogonal model, allowing each component to be optimized independently while maintaining overall prediction accuracy
Solution Approach 2:
The model transforms the prediction approach by changing from single-parameter assessments to multi-parameter orthogonal assessment. It introduces weighted integration of multiple independent metrics (transactivation levels, binding affinities, and their interactions) to capture the complex interplay between oncogenic advantage and immunogenic cost, thereby improving prediction accuracy without excessive complexity
2Measurement precision
If a multi-parameter orthogonal model is applied to accurately predict mutant p53 fitness, then prediction accuracy improves, but the computational complexity and data requirements increase
Solution Approach 1:
The computational task is segmented into separate metric calculations (pro-oncogenic advantage from transactivation data, immunogenic cost from binding affinity data) that can be performed independently using specialized algorithms for each data type, reducing the overall computational burden compared to a single complex integrated model
Solution Approach 2:
The multi-parameter orthogonal model serves multiple functions: it integrates diverse data types (transactivation levels, binding affinities), performs weighted optimization, and generates fitness predictions. This universal framework handles various input parameters through a unified computational approach, making the complex task more manageable
Data Source
AI summary
The present technology relates to methods, computing devices, and systems for predicting the fitness of mutant p53 based on the loss of transcription factor function and immunogenicity of a particular TP53 mutation. The fitness of mutant p53 may be used to determine whether a patient will benefit from a particular anti-cancer therapy such as immune checkpoint inhibitor therapy, adoptive T-cell therapy, or prophylactic cancer vaccine therapy.